Ari M. Melnick

Department of Medicine, Weill Cornell Medical College

Affiliated withWeill Cornell Medical College

Research Area

Biography

Ari M. Melnick has not added Biography.
If you are Ari M. Melnick and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 109	2015
Publication title Cited by 20	2015

Other Publications

Article	Year
The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. Blood\| PubMed ID: 14982881	2004
The theoretical basis of transcriptional therapy of cancer: can it be put into practice? Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15867201	2005
Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics. Cancer research\| PubMed ID: 18593891	2008
BCL6 is critical for the development of a diverse primary B cell repertoire. The Journal of experimental medicine\| PubMed ID: 20498019	2010
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood\| PubMed ID: 20736451	2010
Epigenetics in AML. Best practice & research. Clinical haematology\| PubMed ID: 21130408	2010
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. The Journal of experimental medicine\| PubMed ID: 21911423	2011
SYK inhibition and response prediction in diffuse large B-cell lymphoma. Blood\| PubMed ID: 22025527	2011
The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell metabolism\| PubMed ID: 22465074	2012
Oncogene-mediated alterations in chromatin conformation. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22615383	2012
Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. PloS one\| PubMed ID: 22808135	2012
Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research\| PubMed ID: 22893614	2013
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. Cancer research\| PubMed ID: 23066032	2013
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Cancer discovery\| PubMed ID: 23107779	2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer research\| PubMed ID: 23233736	2013
Notch activation inhibits AML growth and survival: a potential therapeutic approach. The Journal of experimental medicine\| PubMed ID: 23359069	2013
BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements. Blood\| PubMed ID: 23476051	2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer cell\| PubMed ID: 23680150	2013
New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes. Current opinion in immunology\| PubMed ID: 23725655	2013
Differentiation therapy for IDH1/2 mutant malignancies. Cell research\| PubMed ID: 23732524	2013
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 24821775	2014
Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia. Science translational medicine\| PubMed ID: 24871132	2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells. Oncotarget\| PubMed ID: 25026298	2014
Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas. Genome biology\| PubMed ID: 25123191	2014
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood\| PubMed ID: 25320243	2015